|
1
|
Weinkle AP, Doktor V and Emer J: Update on
the management of rosacea. Clin Cosmet Investig Dermatol.
8:159–177. 2015.PubMed/NCBI
|
|
2
|
Gallo RL, Granstein RD, Kang S, Mannis M,
Steinhoff M, Tan J and Thiboutot D: Standard classification and
pathophysiology of rosacea: The 2017 update by the National Rosacea
Society Expert Committee. J Am Acad Dermatol. 78:148–155. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Egeberg A, Hansen PR, Gislason GH and
Thyssen JP: Patients with Rosacea have increased risk of depression
and anxiety disorders: A Danish Nationwide Cohort Study.
Dermatology. 232:208–213. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Libon F, El Hayderi L, Nikkels-Tassoudji
N, Dezfoulian B and Nikkels AF: Rosacea. Rev Med Liege. 70:179–185.
2015.(In French). PubMed/NCBI
|
|
5
|
Gonzalez-Hinojosa D, Jaime-Villalonga A,
Aguilar-Montes G and Lammoglia-Ordiales L: Demodex and rosacea: Is
there a relationship? Indian J Ophthalmol. 66:36–38. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cohen PR: Follicular contact dermatitis
revisited: A review emphasizing neomycin-associated follicular
contact dermatitis. World J Clin Cases. 2:815–821. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chang YS and Huang YC: Role of Demodex
mite infestation in rosacea: A systematic review and meta-analysis.
J Am Acad Dermatol. 77:441–447.e6. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Luo Y, Sun YJ, Zhang L and Luan XL:
Treatment of mites folliculitis with an ornidazole-based sequential
therapy: A randomized trial. Medicine (Baltimore). 95:e41732016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zarei F and Soleimaninejad M: Role of
growth factors and biomaterials in wound healing. Artif Cells
Nanomed Biotechnol. 1–6. 2018.PubMed/NCBI
|
|
10
|
Jinfeng L, Yunliang W, Xinshan L, Shanshan
W, Chunyang X, Peng X, Xiaopeng Y, Zhixiu X, Honglei Y, Xia C, et
al: The effect of MSCs derived from the human umbilical cord
transduced by fibroblast growth factor-20 on Parkinson's disease.
Stem Cells Int. 2016:50167682016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Meduri A, Scorolli L, Scalinci SZ, Grenga
PL, Lupo S, Rechichi M and Meduri E: Effect of the combination of
basic fibroblast growth factor and cysteine on corneal epithelial
healing after photorefractive keratectomy in patients affected by
myopia. Indian J Ophthalmol. 62:424–428. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wilkin J, Dahl M, Detmar M, Drake L,
Feinstein A, Odom R and Powell F: Standard classification of
rosacea: Report of the National Rosacea Society Expert Committee on
the classification and staging of rosacea. J Am Acad Dermatol.
46:584–587. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rong L, Ding T and Zhou Y: Different
methods in the treatment of rosacea and effect observation of
staging. Sichuan Medical J. 35:444–445. 2014.
|
|
14
|
Tan JK: Evaluation of clinical severity by
acne grading and lesion counting. Springer Berlin. (Heidelberg).
325–330. 2014.
|
|
15
|
Luo Y, Zhang LI, Sun YJ, Du H and Yang GL:
Syringotropic mycosis fungoides responding well to VELP
chemotherapy: A case report. Exp Ther Med. 11:2254–2258. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Alebachew T, Yismaw G, Derabe A and Sisay
Z: Staphylococcus aureusburn wound infection among patients
attending yekatit 12 hospital burn unit, addis ababa, ethiopia.
Ethiop J Health Sci. 22:2092012.PubMed/NCBI
|
|
17
|
Del Rosso JQ, Tanghetti EA, Baldwin HE,
Rodriguez DA and Ferrusi IL: The burden of illness of
erythematotelangiectatic rosacea and papulopustular rosacea:
Findings from a web-based survey. J Clin Aesthet Dermatol.
10:17–31. 2017.PubMed/NCBI
|
|
18
|
Rainer BM, Kang S and Chien AL: Rosacea:
Epidemiology, pathogenesis, and treatment. Dermatoendocrinol.
9:e13615742017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mikkelsen CS, Holmgren HR, Kjellman P,
Heidenheim M, Kappinnen A, Bjerring P and Huldt-Nystrøm T: Rosacea:
A clinical review. Dermatol Reports. 8:63872016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tüzün Y, Wolf R, Kutlubay Z, Karakuş O and
Engin B: Rosacea and rhinophyma. Clin Dermatol. 32:35–46. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Oge LK, Muncie HL and Phillips-Savoy AR:
Rosacea: Diagnosis and treatment. Am Fam Physician. 92:187–196.
2015.PubMed/NCBI
|
|
22
|
van Zuuren EJ, Fedorowicz Z, Carter B, van
der Linden MM and Charland L: Interventions for rosacea. Cochrane
Database Syst Rev. CD003262. 2015. View Article : Google Scholar
|
|
23
|
Ebbelaar CCF, Venema AW and Van Dijk MR:
Topical ivermectin in the treatment of papulopustular rosacea: A
systematic review of evidence and clinical guideline
recommendations. Dermatol Ther (Heidelb). 8:379–387. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Piwnica D, Pathak A, Schäfer G and
Docherty JR: In vitro safety pharmacology profiling of topical
α-adrenergic agonist treatments for erythema of rosacea. Drugs R D.
18:87–90. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Piwnica D, M Pathak A, Schafer G and
Docherty JR: In vitro safety pharmacology profiling of
topical alpha-adrenergic agonist treatments for erythema in wounded
skin. J Cell Sci. 125:5690–5701. 2012.PubMed/NCBI
|
|
26
|
Zbinden A, Browne S, Altiok EI, Svedlund
FL, Jackson WM and Healy KE: Multivalent conjugates of basic
fibroblast growth factor enhance in vitro proliferation and
migration of endothelial cells. Biomater Sci. 6:1076–1083. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen G, Ren J, Deng Y, Wu X, Huang J, Wang
G, Zhao Y and Li J: An injectable, wound-adapting, self-healing
hydrogel for fibroblast growth factor 2 delivery system in tissue
repair applications. J Biomed Nanotechnol. 13:1660–1672. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qu Y, Cao C, Wu Q, Huang A, Song Y, Li H,
Zuo Y, Chu C, Li J and Man Y: The dual delivery of KGF and bFGF by
collagen membrane to promote skin wound healing. J Tissue Eng Regen
Med. 12:1508–1518. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Marcelo KL, Goldie LC and Hirschi KK:
Regulation of endothelial cell differentiation and specification.
Circ Res. 112:1272–1287. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Taieb A, Ortonne JP, Ruzicka T,
Roszkiewicz J, Berth-Jones J, Peirone MH and Jacovella J;:
Ivermectin Phase III study group: Superiority of ivermectin 1%
cream over metronidazole 0.75% cream in treating inflammatory
lesions of rosacea: A randomized, investigator-blinded trial. Br J
Dermatol. 172:1103–1110. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
DuBois J, Dover JS, Jones TM, Weiss RA,
Berk DR and Ahluwalia G: Phase 2 randomized, dose-ranging study of
oxymetazoline cream for treatment of persistent facial erythema
associated with rosacea. J Drugs Dermatol. 17:308–316.
2018.PubMed/NCBI
|
|
32
|
Gold LS, Papp K, Lynde C, Lain E,
Gooderham M, Johnson S and Kerrouche N: Treatment of rosacea with
concomitant use of topical ivermectin 1% cream and brimonidine
0.33% gel: A randomized, vehicle-controlled study. J Drugs
Dermatol. 16:909–916. 2017.PubMed/NCBI
|
|
33
|
Friedman LM, Furberg CD, DeMets D,
Reboussin DM and Granger CB: Fundamentals of clinical trials.
Springer. 2015.
|
